type K99 infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9211309
APP PUB NO 20150004141A1
SERIAL NO

14316019

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a composition comprising EK99P-1, a bacteriophage isolated from nature and capable of infecting E. coli type K99 so as to kill the same, as an active ingredient, and a method for preventing and treating E. coli type K99 infections using the said composition. According to the present invention, the bacteriophage EK99P-1, an active ingredient of the composition, has a killing activity against E. coli type K99 and has the genome represented by SEQ. ID. NO: 1.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INTRON BIOTECHNOLOGY INCSANGDAEWON-DONG #701-704 JUNGANG INDUSPIA 137 SAGIMAKGOL-RO-JUNGWON-GU SEONGNAM-SI GYEONGGI-DO 13202

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jun, Sooyoun Seoul, KR 12 53
Kang, Sanghyeon Seoul, KR 19 120
Paik, Hyoungrok Jeollanam-Do, KR 4 25
Son, Jeesoo Seoul, KR 8 66
Yoon, Seongjun Seoul, KR 23 139

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00